Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
CRVW insiders and related entities filed to sell up to 144,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services under Rule 144, with a proposed aggregate value of $10,542,240.00.
The filing also lists extensive recent Rule 10b5-1 sales from April to July 2026 by Brannin McBee, Meghan Bennett and several related trusts, including blocks such as 200,000 shares for $21,806,780.00 on April 27, 2026 and recurring 144,000-share sales on multiple June and July 2026 dates.
CRWV shareholders filed a notice for the potential sale of 25,000 shares of common stock, held as founders shares and to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. The proposed sale, with an aggregate market value of $1,830,250.00, is referenced for trading on NASDAQ around 07/20/2026. The disclosure also lists extensive Rule 10b5-1 sales over the past three months by Brannin McBee, Meghan Bennett and several related trusts, including a single 200,000‑share sale on 04/27/2026.
CRWV has a notice of proposed sale of common stock under Rule 144. A broker, Morgan Stanley Smith Barney LLC Executive Financial Services, is listed to sell 3,000 common shares, with an indicated aggregate value of $219,630.00, on or after July 20, 2026 on NASDAQ.
The filing also lists extensive prior 10b5-1 plan sales of CRWV common stock over the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities, showing multiple large-volume transactions in 2026.
A holder of CRWV common stock filed to potentially sell 500 shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $36,605.00 as of a planned sale date of July 20, 2026 on NASDAQ.
The 500 shares are listed as Founders Shares acquired on February 25, 2019. The filing also lists multiple prior Rule 10b5-1 sales of CRWV common stock over the past three months by Brannin McBee, Meghan Bennett and related trusts, including individual transactions such as 200,000 shares sold for $21,806,780.00 on April 27, 2026.
A shareholder of CRWV filed a notice to sell up to 40,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of about $2,928,400, after 07/20/2026 on NASDAQ.
The filing classifies the securities as “Founders Shares” originally acquired on 02/25/2019. It also lists extensive prior Rule 10b5-1 plan sales during the past three months by various related holders and trusts. Reported total shares outstanding are 447,573,939.
CRWV filed a notice of proposed sale of common stock. The filing lists 12,500 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services at an aggregate value of $915,125.00, with a proposed sale date of July 20, 2026 on NASDAQ.
The filing also details extensive Rule 10b5-1 trading plan sales of CRWV common stock over the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities. Individual transactions include, for example, a 200,000-share sale for $21,806,780.00 on April 27, 2026 and recurring 144,000-share sales on multiple June and July 2026 dates.
A holder of CRWV common stock filed to sell 25,000 founders’ shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,830,250, on or after July 20, 2026 under Rule 144. The filing also lists extensive recent Rule 10b5-1 plan sales of CRWV common stock by Brannin McBee, Meghan Bennett and related trusts over the past three months, detailing multiple transactions in blocks up to 200,000 shares each.
CoreWeave CEO and President Michael N. Intrator, a more-than-10% stockholder, reported several open-market transactions in the company’s Class A Common Stock on July 14, 2026. Through Omnadora Capital LLC and direct holdings, entities associated with him sold a total of 307,692 Class A shares at weighted-average prices between $78.48 and $85.78 per share, with certain sales executed pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2025.
The filing also reports the conversion of 107,692 shares of Class B Common Stock held indirectly through Omnadora into Class A. After these transactions, Intrator continues to hold substantial equity, including 2,676,815 Class A shares directly, 21,867,489 Class B shares directly (each convertible 1-for-1 into Class A), and additional Class B positions held by his spouse and family trusts.
CoreWeave, Inc. Chief Development Officer Brannin McBee reported indirect transactions in Class A and Class B Common Stock on July 13, 2026. Family and grantor retained annuity trusts associated with McBee sold a total of 53,000 Class A shares in multiple open-market trades and converted 52,500 Class B shares into Class A. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2026, and related trusts continue to hold Class A positions, including 6,408 shares in the Canis Minor 2025 GRAT, 20,502 shares in the Canis Major 2025 GRAT and 51,259 shares in the Canis Major SM Trust.
CoreWeave, Inc. Chief Development Officer Brannin McBee and related entities reported multiple transactions in CoreWeave Class A and Class B Common Stock on July 13, 2026. The filing shows 197,000 Class A shares sold in open‑market transactions and 197,000 Class B shares converted into Class A.
After these transactions, McBee holds 323,263 Class A shares directly and 6,186,894 Class B shares directly, with additional Class B holdings held through trusts and a spouse. A footnote notes that at least one reported sale was effected pursuant to a Rule 10b5‑1 trading plan adopted on March 5, 2026.